Physician profile
Haritha Narla
NPI 1245356419
$1,591.12
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,383 · 2020: $170 · 2021: $37.95.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $232.09 | 2019-2020 | |
| Pfizer INC. | $177.94 | 2019-2020 | |
| Abbvie INC. | $163.31 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $119.92 | 2019-2020 | |
| Janssen Biotech, INC. | $99.40 | 2019-2020 | |
| Celgene Corporation | $95.51 | 2019 | |
| Lilly USA, LLC | $80.71 | 2019 | |
| Novartis Pharmaceuticals Corporation | $75.84 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $75.58 | 2019 | |
| Genentech USA, INC. | $67.47 | 2019-2020 | |
| Glaxosmithkline, LLC. | $64.53 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $62.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $43.52 | 2019 | |
| Radius Health, INC. | $43.17 | 2019 | |
| Ucb, INC. | $38.74 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $34.95 | 2019 | |
| Medexus Pharma, INC. | $25.31 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $15.09 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.63 | 2019 | |
| Merck Sharp & Dohme LLC | $14.11 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.00 | 2019 | |
| Hikma Pharmaceuticals USA | $10.97 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haritha Narla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.